Page last updated: 2024-08-24

gemcitabine and Femoral Neoplasms

gemcitabine has been researched along with Femoral Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altiok, S; Bui, MM; Foroutan, P; Gillies, RJ; Kreahling, JM; Letson, D; Martinez, G; Raghavan, M; Razabdouski, T; Reed, D1
Grignani, G; Martín-Broto, J; Reichardt, P; Schuler, M1
Brodsky, I; Rosenbluth, JZ; Styler, MJ; Zak, D1

Reviews

1 review(s) available for gemcitabine and Femoral Neoplasms

ArticleYear
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
    Clinical advances in hematology & oncology : H&O, 2005, Volume: 3, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Doxorubicin; Etoposide; Femoral Neoplasms; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Palliative Care; Salvage Therapy; Scalp; Skin Neoplasms; Thoracotomy

2005

Trials

1 trial(s) available for gemcitabine and Femoral Neoplasms

ArticleYear
Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Animals; Antimetabolites, Antineoplastic; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line, Tumor; Child; Child, Preschool; Deoxycytidine; Drug Synergism; Female; Femoral Neoplasms; Gemcitabine; Humans; Male; Mice; Mice, SCID; Middle Aged; Neoplasm Transplantation; Nuclear Proteins; Osteosarcoma; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Transplantation, Heterologous; Xenograft Model Antitumor Assays

2013

Other Studies

1 other study(ies) available for gemcitabine and Femoral Neoplasms

ArticleYear
Trabectedin clinical cases: use according to indication in diverse clinical scenarios.
    Future oncology (London, England), 2015, Volume: 11, Issue:11 Suppl

    Topics: Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Contraindications; Dacarbazine; Deoxycytidine; Dioxoles; Female; Femoral Neoplasms; Gemcitabine; Humans; Hysterectomy; Ifosfamide; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Radionuclide Imaging; Remission Induction; Salvage Therapy; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Thigh; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome; Uterine Neoplasms

2015